DERL1 and breast cancer: Whereas cytosolic staining was found to be strongly present in a breast cancer case (Figure 1a), no staining was detected in sections from the same sample when the section was subject to immunohistochemical analysis using the antibody against derlin-1 that was pre-incubated with peptide antigen (Figure 1b).